Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Abiomed Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $373.63
No. shares of common stock outstanding 45,091,184
US$ in thousands
Common equity (market value)1 16,847,419
Add: Class B Preferred Stock, $.01 par value; none issued and outstanding (per books)
Total equity 16,847,419
Add: Current portion of capital lease obligation (per books)
Add: Capital lease obligation, net of current portion (per books)
Total equity and debt 16,847,419
Less: Cash and cash equivalents 132,818
Less: Short-term marketable securities 625,789
Enterprise value (EV) 16,088,812

Based on: 10-K (reporting date: 2022-03-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 373.63 × 45,091,184


Historical Enterprise Value (EV)

Abiomed Inc., EV calculation

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Share price1, 2 $235.75 $280.00 $196.32 $262.64 $394.46 $135.88
No. shares of common stock outstanding1 45,563,937 45,295,979 44,956,959 45,124,729 44,477,837 43,819,330
US$ in thousands
Common equity (market value)3 10,741,698 12,682,874 8,825,950 11,851,559 17,544,728 5,954,171
Add: Class B Preferred Stock, $.01 par value; none issued and outstanding (book value)
Total equity 10,741,698 12,682,874 8,825,950 11,851,559 17,544,728 5,954,171
Add: Current portion of capital lease obligation (book value) 799
Add: Capital lease obligation, net of current portion (book value) 15,539
Total equity and debt 10,741,698 12,682,874 8,825,950 11,851,559 17,544,728 5,970,509
Less: Cash and cash equivalents 132,818 232,710 192,341 121,021 42,975 39,040
Less: Short-term marketable securities 625,789 350,985 250,775 370,677 319,274 190,908
Enterprise value (EV) 9,983,091 12,099,179 8,382,834 11,359,861 17,182,479 5,740,561

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Abiomed Inc. Annual Report.

3 2022 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 235.75 × 45,563,937

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Abiomed Inc. EV increased from 2020 to 2021 but then slightly decreased from 2021 to 2022 not reaching 2020 level.